MedicarePartD.guide

A non-government resource built from CMS public data

Rytary on HealthSpring Assurance Rx (S5617-068)

carbidopa-levodopa extended-release

Covered, with step therapy.

Tier 4 (non-preferred drug). No quantity limit.

33%
Patient pays / month, after deductible
33%
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

RYTARY 95/23.75 mg Capsule, Extended Release at a preferred retail pharmacy. Other covered strengths are listed below.

Prior authNot required· Step therapy applies· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 4 covered strengths and forms
FormTierPatient pays / monthLimits
RYTARY 95/23.75 mg Capsule, Extended Release433%ST
RYTARY 145/36.25 mg Capsule, Extended Release433%ST
RYTARY 195/48.75 mg Capsule, Extended Release433%ST
RYTARY 245/61.25 mg Capsule, Extended Release433%ST

Other Parkinson's drugs on this plan

Verify with the plan before prescribing or filling. Member services: (800)222-6700. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5617-068